<DOC>
	<DOCNO>NCT00220610</DOCNO>
	<brief_summary>Subjects receive rTMS daily 10 consecutive weekday ( five session per week ) , 20 minute per session.During rTMS session , coil center flat right parietal cortex . We follow patient 12 week 2 week tm ( follow-up period ) measure depression different rating scale . We hypothesize rTMS positive effect treatment depression</brief_summary>
	<brief_title>REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN Treatment DEPRESSION</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>In outpatient age 16 65 meet DSMIV criterion major depressive episode , score 25 high 10item Montgomery Asberg Depression Rating Scale ( MADRS ) include A history epilepsy medical disorder preclude administration rTMS . Only SSRI 's , Mirtazapine Promethazine psychotropic medication accept dosage antidepressive medication change 6 week , dosage Promethazine change 2 week prior inclusion . Antidepressive medication remain stable 14 week study . Furthermore : schizophrenic disorder , piece metal brain , pacemaker lefthanded patient .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>